Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

On-Site Addiction Treatment With Buprenorphine in HIV Clinical Care Settings

NCT00317460 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT00317460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00317460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
On-Site Addiction Treatment With Buprenorphine in HIV Clinical Care Settings
Lead sponsor
Yale University
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2005
Completion date
October 31, 2012
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aids, drug addiction, hiv infections, human immunodeficiency virus, substance-related disorders